10X Genomics Inc Class A (TXG)
EBITDA Margin
-5.95%
Quarterly · Period ending:
TXG EBITDA Margin
Latest reported-5.95%period ending
Latest reported-5.95%period ending
TXG Quarterly EBITDA Margin (-51.57% → -5.95%)
Quarterly ebitda margin
High-resolution chart · PNG
TXG ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -5.9463% | |
| -0.6212% | |
| 38.2684% | |
| -10.7052% | |
| 26.9802% | |
| -15.2967% | |
| -22.9159% | |
| -15.6184% | |
| -17.0982% | |
| -32.8412% | |
| -18.9609% | |
| -52.2786% | |
| -33.2961% | |
| -30.5462% | |
| -5.0015% | |
| -24.2661% | |
| -48.2318% | |
| -29.3381% | |
| -5.8887% | |
| -7.3058% | |
| -2.2116% | |
| -4.1835% | |
| -359.0244% | |
| -83.5304% | |
| -81.508% | |
| -22.1445% | |
| -4.2357% | |
| -11.185% | |
| -18.1211% | |
| -3.5126% | |
| -147.9487% | |
| -40.0743% | |
| -13.7554% | |
| -51.5688% |